A recent decision by the US Supreme Court may lead to increased legal action within the healthcare sector, says one expert. Federal Trade Commission deputy assistant director Sara Razi suggested that the Court’s decision, made last February, strengthened federal antitrust lawyers when clarifying when state antitrust law can trump federal; the Court unanimously agreed that “state-action immunity is disfavored” in FTC vs. Phoebe Putney Health System. The FTC sued the health group over a merger, approved by Georgia’s state hospital regulators. According to Razi, the ruling was “manna from heaven” and suggested that the Court’s ruling demonstrated unity between liberals and conservatives when it comes to federal antitrust exemptions. According to Razi, this may lead to more legal action taken within the healthcare sector as federals find the support of Supreme Court precedence.
Full Content: Thomson Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Kenya’s Competition Authority Proposes Tougher Regulations on Big Tech
May 30, 2024 by
CPI
KKR Secures EU Antitrust Approval for $24 Billion Acquisition of Telecom Italia’s Fixed-Line Network
May 30, 2024 by
CPI
European Court Sides with Tech Giants in Italian Regulatory Dispute
May 30, 2024 by
CPI
US Steel and Nippon Steel Secure International Approvals for $14.9B Merger
May 30, 2024 by
CPI
EU Watchdog Mandates Boardroom Accountability for AI in Banks
May 30, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Merger Guidelines Retrospective
May 21, 2024 by
CPI
Mergers of Complements
May 21, 2024 by
CPI
Personality Traits, Private Equity, and Merger Analysis
May 21, 2024 by
CPI
The 2023 Merger Guidelines: Lessons in the Importance of Incipiency, Modern Economics, and Monopsony
May 21, 2024 by
CPI
The 2023 Merger Guidelines: Sharpening Merger Analysis
May 21, 2024 by
CPI